|
|
|
Volumn 48, Issue 5, 2008, Pages 72-
|
|
Telmisartan, ramipril, or both in patients at high risk for vascular events. Results of the ONTARGET trial
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
BENZIMIDAZOLE DERIVATIVE;
BENZOIC ACID DERIVATIVE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
RAMIPRIL;
TELMISARTAN;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
FEMALE;
HEALTH;
HUMAN;
INCIDENCE;
MALE;
MULTICENTER STUDY;
PERIPHERAL VASCULAR DISEASE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
TREATMENT OUTCOME;
AGED;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BENZIMIDAZOLES;
BENZOATES;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
INCIDENCE;
MALE;
PERIPHERAL VASCULAR DISEASES;
RAMIPRIL;
RISK FACTORS;
TREATMENT OUTCOME;
WORLD HEALTH;
|
|
EID: 54449083625
PISSN: 00229040
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
